All data are based on the daily closing price as of April 28, 2025
l

L&C Bio

290650.KQ
14.76 USD
-0.13
-0.87%

Overview

Last close
14.76 usd
Market cap
334.76M usd
52 week high
26.40 usd
52 week low
10.84 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
6.7495
Price/Book Value
1.7072
Enterprise Value
405.45M usd
EV/Revenue
8.1175
EV/EBITDA
3.9604

Key financials

Revenue TTM
49.95M usd
Gross Profit TTM
24.75M usd
EBITDA TTM
6.44M usd
Earnings per Share
N/A usd
Dividend
0.03 usd
Total assets
322.67M usd
Net debt
68.10M usd

About

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top